AstraZeneca Pharma India Statistics

Total Valuation

NSE:ASTRAZEN has a market cap or net worth of INR 229.10 billion. The enterprise value is 224.09 billion.

Market Cap	229.10B
Enterprise Value	224.09B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	Jul 18, 2025

Share Statistics

Current Share Class	25.00M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.14M

Valuation Ratios

The trailing PE ratio is 197.95.

PE Ratio	197.95
Forward PE	n/a
PS Ratio	13.35
PB Ratio	29.74
P/TBV Ratio	29.77
P/FCF Ratio	360.17
P/OCF Ratio	350.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 88.24, with an EV/FCF ratio of 352.29.

EV / Earnings	193.62
EV / Sales	13.06
EV / EBITDA	88.24
EV / EBIT	104.73
EV / FCF	352.29

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.05.

Current Ratio	1.91
Quick Ratio	1.03
Debt / Equity	0.05
Debt / EBITDA	0.14
Debt / FCF	0.56
Interest Coverage	146.56

Financial Efficiency

Return on equity (ROE) is 15.62% and return on invested capital (ROIC) is 17.57%.

Return on Equity (ROE)	15.62%
Return on Assets (ROA)	10.30%
Return on Invested Capital (ROIC)	17.57%
Return on Capital Employed (ROCE)	26.25%
Revenue Per Employee	28.60M
Profits Per Employee	1.93M
Employee Count	600
Asset Turnover	1.32
Inventory Turnover	2.48

Taxes

In the past 12 months, NSE:ASTRAZEN has paid 406.20 million in taxes.

Income Tax	406.20M
Effective Tax Rate	25.98%

Stock Price Statistics

The stock price has increased by +35.23% in the last 52 weeks. The beta is 0.03, so NSE:ASTRAZEN's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+35.23%
50-Day Moving Average	8,892.75
200-Day Moving Average	7,767.53
Relative Strength Index (RSI)	57.38
Average Volume (20 Days)	43,614

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ASTRAZEN had revenue of INR 17.16 billion and earned 1.16 billion in profits. Earnings per share was 46.30.

Revenue	17.16B
Gross Profit	7.53B
Operating Income	2.14B
Pretax Income	1.56B
Net Income	1.16B
EBITDA	2.54B
EBIT	2.14B
Earnings Per Share (EPS)	46.30

Full Income Statement

Balance Sheet

The company has 5.37 billion in cash and 357.30 million in debt, giving a net cash position of 5.01 billion.

Cash & Cash Equivalents	5.37B
Total Debt	357.30M
Net Cash	5.01B
Net Cash Per Share	n/a
Equity (Book Value)	7.70B
Book Value Per Share	308.14
Working Capital	6.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 653.60 million and capital expenditures -17.50 million, giving a free cash flow of 636.10 million.

Operating Cash Flow	653.60M
Capital Expenditures	-17.50M
Free Cash Flow	636.10M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.89%, with operating and profit margins of 12.47% and 6.74%.

Gross Margin	43.89%
Operating Margin	12.47%
Pretax Margin	9.11%
Profit Margin	6.74%
EBITDA Margin	14.80%
EBIT Margin	12.47%
FCF Margin	3.71%

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.35%.

Dividend Per Share	32.00
Dividend Yield	0.35%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	3
Payout Ratio	51.84%
Buyback Yield	0.01%
Shareholder Yield	0.36%
Earnings Yield	0.51%
FCF Yield	0.28%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4